ProCE Banner Activity

A Community Practitioner’s Guide to Contemporary Management of Polycythemia Vera: Data Review and Case Challenges Illustrating Current Best Practice


Download these slides covering community team management of polycythemia vera, including risk stratification directing cytoreductive therapy, dose optimization considering response and tolerance, and identification of factors directing treatment switch.

Released: July 25, 2023



Andrew Kuykendall

Andrew Kuykendall, MD

Assistant Member
Department of Malignant Hematology
H. Lee Moffitt Cancer Center
Tampa, Florida

John Mascarenhas

John Mascarenhas, MD

Director, Adult Leukemia Program
Leader, Myeloproliferative Disorders Clinical Research Program
Division of Hematology/Oncology
Tisch Cancer Institute 
Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from Incyte Corporation and PharmaEssentia USA Corporation.

Incyte Corporation

PharmaEssentia USA Corporation